Platelets and megakaryocytes in cancer
Platelets and megakaryocytes in cancer Emma C. Josefsson 1),2) 1)…
Ler MaisHemophilia B Leyden: characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry
Hemophilia B Leyden: characteristics and natural history in the International…
Ler MaisComplement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia
Complement activation as a biomarker for platelet-activating antibodies in heparin-induced…
Ler MaisThe management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia.
The management of liver disease in people with congenital bleeding…
Ler MaisMolecular basis of platelet granule defects
Molecular basis of platelet granule defects Helen H.Y. Yao 1),…
Ler MaisHemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric patients undergoing corrective heart surgery
Hemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric…
Ler MaisDeconstructing fibrin(ogen) structure
Deconstructing fibrin(ogen) structure Rebecca A. Risman1 ∙ Mehmet Sen2 ∙…
Ler MaisThe severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cells
The severe von Willebrand disease variant p.M771V leads to impaired…
Ler MaisDevelopment of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL
Development of a rapid and fully automated factor VIII inhibitor…
Ler MaisCharacterization of recombinant factor IX fusion proteins enabling subcutaneous administration
Characterization of recombinant factor IX fusion proteins enabling subcutaneous administration…
Ler Mais